Clinical Trials Directory

Trials / Completed

CompletedNCT04317053

Multi-Center Randomized Controlled Trial of Relay- NYC's Nonfatal Overdose Response Program

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
253 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The New York City (NYC) Department of Health and Mental Hygiene (DOHMH) has implemented Relay, a novel program that engages and intervenes with individuals in the ED following an opioid OD and for the next 90 days, with the goal of preventing subsequent OD events. The proposed randomized controlled trial will evaluate the impact of Relay on preventing subsequent opioid-related adverse events. A total of 350 eligible individuals with nonfatal opioid OD presenting to one of four participating EDs will be enrolled and randomized to one of two arms: 1) site-directed care (SDC) or 2) Relay-peer-delivered OD education and treatment linkage, including 90 days of peer navigation. Outcomes will be measured for 12 months through interviews and administrative health data.

Detailed description

Relay is a novel program that engages and intervenes with individuals in the ED following an opioid OD and for the next 90 days, with the goal of preventing subsequent OD events. Relay is delivered by trained peer navigators, who are DOHMH staff with lived substance use experience. Relay navigators provide counseling, linkage to services, and OD prevention education.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRELAYRelay is a novel program that engages and intervenes with individuals in the ED following an opioid OD and for the next 90 days, with the goal of preventing subsequent OD events. Relay is delivered by trained peer navigators, who are DOHMH staff with lived substance use experience. Relay navigators provide counseling, linkage to services, and OD prevention education.

Timeline

Start date
2020-10-08
Primary completion
2023-07-01
Completion
2023-07-01
First posted
2020-03-20
Last updated
2024-11-25
Results posted
2024-11-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04317053. Inclusion in this directory is not an endorsement.